论文部分内容阅读
目的比较甲氨蝶呤联合米非司酮与单用甲氨蝶呤治疗异位妊娠的疗效评价。方法随机抽取2016年2月~2017年2月我院收治的异位妊娠患者80例,分为X组(n=40)和Y组(n=40)。Y组患者进行甲氨蝶呤治疗,X组患者在Y组患者的基础上进行米非司酮联合治疗。对比X、Y两组患者的治疗效果以及治疗前后的血β-HCG、包块直径。结果相对于Y组患者的治疗效果(72.5%),X组患者的(95%)较高,(P<0.05),具备一定的统计学意义;相对于Y组患者治疗前的血β-HCG、包块直径,X组患者无明显差异(P>0.05);相对于Y组患者治疗后的血β-HCG、包块直径,X组患者的较低,(P<0.05),具备一定的统计学意义。结论治疗异位妊娠,甲氨蝶呤联合米非司酮的效果远优于单用甲氨蝶呤,疗效确切,值得借鉴和推广。
Objective To compare the efficacy of methotrexate with mifepristone and methotrexate alone in the treatment of ectopic pregnancy. Methods Totally 80 patients with ectopic pregnancy admitted to our hospital from February 2016 to February 2017 were randomly divided into two groups: group X (n = 40) and group Y (n = 40). Patients in group Y were treated with methotrexate, and patients in group X were treated with mifepristone on the basis of group Y patients. Comparison of X, Y treatment of patients and before and after treatment of blood β-HCG, mass diameter. Results Compared with the treatment of patients in group Y (72.5%), the patients in group X (95%) were higher (P <0.05) and had certain statistical significance. Compared with those in group Y, (P> 0.05). Compared with the patients in group Y, the blood β-HCG, mass diameter and the patients in group X were lower (P <0.05), and had a certain Statistical significance. Conclusion The treatment of ectopic pregnancy, methotrexate combined with mifepristone is far superior to methotrexate alone, curative effect is worthy of reference and promotion.